Preeclampsia transforms membrane N-glycome in human placenta
Authorized Users Only
2016
Authors
Robajac, DraganaVanhooren, Valerie
Masnikosa, Romana
Miković, Zeljko
Mandić, Vesna
Libert, Claude
Nedić, Olgica
Article (Published version)
Metadata
Show full item recordAbstract
Posttranslational modifications (PTM) which accompany pathological conditions affect protein structure, characteristics and modulate its activity. Glycosylation is one of the most frequent PTM influencing protein folding, localisation and function. Hypertension is a common gestational complication, which can lead to foetal growth restriction (IUGR) and even to foetal or maternal death. In this work we focused on the impact of preeclampsia complicated with IUGR on placental membrane N-glycome. Results have shown that preeclampsia reduced fucosylation of placental glycans, increased the appearance of paucimannosidic and mannosidic structures with lower number of mannose residues and decreased the amount of glycans with more mannose residues. Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R). It was foun...d that IR present in the IUGR placenta contained significantly less alpha 2,6-Sia. Therefore, glycans on placental membranes alter due to preeclampsia, but changes seen at the level of the entire N-glycome may be different from the changes detected at the level of a specific glycoprotein. The difference recorded due to pathology in one membrane molecule (IR) was not found in another homologous molecule (IGF1R). Thus, besides studying the glycosylation pattern of the entire placental membrane due to preeclampsia, it is inevitable to study directly glycoprotein of interest, as no general assumptions or extrapolations can be made. (C) 2015 Elsevier Inc All rights reserved.
Keywords:
Preeclampsia / IUGR / Glycosylation / Placental membrane / DSA-FACE / IR / IGF1RSource:
Experimental and Molecular Pathology, 2016, 100, 1, 26-30Publisher:
- Elsevier
Funding / projects:
- Structural characterisation of the insulin-like growth factor (IGF) binding proteins and IGF receptors, their interactions with other physiological molecules and alterations in metabolic disorders (RS-MESTD-Basic Research (BR or ON)-173042)
- COST Action [COST-STSM-CM1001-9130]
DOI: 10.1016/j.yexmp.2015.11.029
ISSN: 0014-4800; 1096-0945
PubMed: 26655437
WoS: 000369879100005
Scopus: 2-s2.0-84949575754
Collections
Institution/Community
VinčaTY - JOUR AU - Robajac, Dragana AU - Vanhooren, Valerie AU - Masnikosa, Romana AU - Miković, Zeljko AU - Mandić, Vesna AU - Libert, Claude AU - Nedić, Olgica PY - 2016 UR - https://vinar.vin.bg.ac.rs/handle/123456789/934 AB - Posttranslational modifications (PTM) which accompany pathological conditions affect protein structure, characteristics and modulate its activity. Glycosylation is one of the most frequent PTM influencing protein folding, localisation and function. Hypertension is a common gestational complication, which can lead to foetal growth restriction (IUGR) and even to foetal or maternal death. In this work we focused on the impact of preeclampsia complicated with IUGR on placental membrane N-glycome. Results have shown that preeclampsia reduced fucosylation of placental glycans, increased the appearance of paucimannosidic and mannosidic structures with lower number of mannose residues and decreased the amount of glycans with more mannose residues. Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R). It was found that IR present in the IUGR placenta contained significantly less alpha 2,6-Sia. Therefore, glycans on placental membranes alter due to preeclampsia, but changes seen at the level of the entire N-glycome may be different from the changes detected at the level of a specific glycoprotein. The difference recorded due to pathology in one membrane molecule (IR) was not found in another homologous molecule (IGF1R). Thus, besides studying the glycosylation pattern of the entire placental membrane due to preeclampsia, it is inevitable to study directly glycoprotein of interest, as no general assumptions or extrapolations can be made. (C) 2015 Elsevier Inc All rights reserved. PB - Elsevier T2 - Experimental and Molecular Pathology T1 - Preeclampsia transforms membrane N-glycome in human placenta VL - 100 IS - 1 SP - 26 EP - 30 DO - 10.1016/j.yexmp.2015.11.029 ER -
@article{ author = "Robajac, Dragana and Vanhooren, Valerie and Masnikosa, Romana and Miković, Zeljko and Mandić, Vesna and Libert, Claude and Nedić, Olgica", year = "2016", abstract = "Posttranslational modifications (PTM) which accompany pathological conditions affect protein structure, characteristics and modulate its activity. Glycosylation is one of the most frequent PTM influencing protein folding, localisation and function. Hypertension is a common gestational complication, which can lead to foetal growth restriction (IUGR) and even to foetal or maternal death. In this work we focused on the impact of preeclampsia complicated with IUGR on placental membrane N-glycome. Results have shown that preeclampsia reduced fucosylation of placental glycans, increased the appearance of paucimannosidic and mannosidic structures with lower number of mannose residues and decreased the amount of glycans with more mannose residues. Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R). It was found that IR present in the IUGR placenta contained significantly less alpha 2,6-Sia. Therefore, glycans on placental membranes alter due to preeclampsia, but changes seen at the level of the entire N-glycome may be different from the changes detected at the level of a specific glycoprotein. The difference recorded due to pathology in one membrane molecule (IR) was not found in another homologous molecule (IGF1R). Thus, besides studying the glycosylation pattern of the entire placental membrane due to preeclampsia, it is inevitable to study directly glycoprotein of interest, as no general assumptions or extrapolations can be made. (C) 2015 Elsevier Inc All rights reserved.", publisher = "Elsevier", journal = "Experimental and Molecular Pathology", title = "Preeclampsia transforms membrane N-glycome in human placenta", volume = "100", number = "1", pages = "26-30", doi = "10.1016/j.yexmp.2015.11.029" }
Robajac, D., Vanhooren, V., Masnikosa, R., Miković, Z., Mandić, V., Libert, C.,& Nedić, O.. (2016). Preeclampsia transforms membrane N-glycome in human placenta. in Experimental and Molecular Pathology Elsevier., 100(1), 26-30. https://doi.org/10.1016/j.yexmp.2015.11.029
Robajac D, Vanhooren V, Masnikosa R, Miković Z, Mandić V, Libert C, Nedić O. Preeclampsia transforms membrane N-glycome in human placenta. in Experimental and Molecular Pathology. 2016;100(1):26-30. doi:10.1016/j.yexmp.2015.11.029 .
Robajac, Dragana, Vanhooren, Valerie, Masnikosa, Romana, Miković, Zeljko, Mandić, Vesna, Libert, Claude, Nedić, Olgica, "Preeclampsia transforms membrane N-glycome in human placenta" in Experimental and Molecular Pathology, 100, no. 1 (2016):26-30, https://doi.org/10.1016/j.yexmp.2015.11.029 . .